His research interests are focused on mechanisms of sterile pulmonary inflammation due to inhalation of nanoparticles. Focusing on lung macrophages and the impact of particle characteristics on mechanisms of particle-cell interactions as well as the translation of that knowledge for pulmonary drug delivery using nanocarriers. Methods of investigation are based on alveolar tissue culture models and controlled animal exposures with special emphasis on reporter cell systems and reporter mouse strains combined with lung intravital microscopy in collaboration with Prof. Dr. Markus Rehberg.
In cooperation with Dr. Otmar Schmid (LHI) he coordinates the EU project HARMLESS ‘Advanced High Aspect Ratio and Multicomponent materials: towards comprehensive intelLigent tEsting and Safe by design Strategies
Dr. Stoeger serves as Associate Editor, for the Taylor & Francis, Journal: Nanotoxicology, and the Public Library of Science, Journal: PLOS ONE, as well as for the Editorial board, of the BioMed Central Journal: Particle and Fibre Toxicology.